Sanctuary Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
Sanctuary Advisors's ALNY Position: Q3 2026 in Review
Sanctuary Advisors increased its Alnylam Pharmaceuticals (ALNY) stake by 27% in Q3 2026, buying an estimated $218K and bringing the position to 3,996 shares worth $986K. The position accounts for ﹤0.01% of the portfolio, ranked #1538.
Sanctuary Advisors first reported a position in ALNY in Q2 2024 and has held it in 10 quarters since. The position peaked at $2.82M in Q3 2025. 730 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.
- Sanctuary Advisors held 3,996 shares of Alnylam Pharmaceuticals worth $986K as of Q3 2026.
- Sanctuary Advisors bought 857 Alnylam Pharmaceuticals shares in Q3 2026, an estimated $218K.
- Alnylam Pharmaceuticals made up ﹤0.01% of Sanctuary Advisors's portfolio in Q3 2026, its #1538 holding.
- Sanctuary Advisors first reported a position in Alnylam Pharmaceuticals in Q2 2024 and has held it in 10 quarters since.
- Sanctuary Advisors's Alnylam Pharmaceuticals position peaked at $2.82M in Q3 2025.
- 730 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.
Based on Sanctuary Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.